AAVS1-Targeted Plasmid Integration in AAV Producer Cell Lines
Yuxia Luo1, Amy Frederick1, John M Martin1
11 Sanofi Genzyme , Framingham, Massachusetts.
Human Gene Therapy Methods
|May 16, 2017
Summary
Adeno-associated virus (AAV) producer cell lines were studied for plasmid integration sites. Integration within the AAVS1 locus was common but not essential for high vector yield.
Area of Science:
- Molecular Biology
- Gene Therapy
- Cell Line Engineering
Background:
- Adeno-associated virus (AAV) producer cell lines are crucial for gene therapy vector production.
- These cell lines are typically generated by transfecting cells with a plasmid containing vector sequences, AAV rep and cap genes, and a selectable marker.
- The plasmid's elements suggest potential site-specific integration into the AAVS1 locus on human chromosome 19.
Purpose of the Study:
- To investigate the correlation between plasmid integration site and AAV vector yield.
- To determine if integration within the AAVS1 locus is a common event in AAV producer cell lines.
- To assess whether AAVS1 integration is a prerequisite for high vector production.
Main Methods:
- Southern blot analysis using rep- and AAVS1-specific probes.
- Fluorescence in situ hybridization (FISH) with probes for plasmid, AAVS1, and chr19 markers.
- Inverse PCR assays to confirm integration sites.
Main Results:
- Southern and PCR analyses indicated plasmid integration into the AAVS1 locus in several mid- and high-producing cell lines.
- FISH revealed plasmid integration at AAVS1 in one high-producing line (MW82) but not in another (MW278).
- Integration within AAVS1 was observed in both high and mid-level producers, suggesting it is a widespread phenomenon.
Conclusions:
- Site-specific integration of the AAV plasmid into the AAVS1 locus occurs in several AAV producer cell lines.
- AAVS1 integration is a general phenomenon not exclusively linked to high vector yield.
- Integration within the AAVS1 locus is not an absolute requirement for achieving high AAV vector titers.


